Recently an article published in Molecular Cell reveals the mechanism of a nuclear N 6 -methyladenosine (m 6 A) reader, the YTH domain-containing protein 1 (YTHDC1), in regulating pre-mRNA splicing [1] . Meanwhile, two additional articles published in Nature and Nature Chemical Biology report the first transcriptome-wide maps of A reader, the heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1), which consequently recruits DiGeorge syndrome critical region 8 (DGCR8) and DROSHA complex and promotes the maturation of microRNAs [13, 14] . YTHDC1, as reflected by its name, contains the YTH domain that selectively binds to m 6 A [15] . Unlike the other two cytoplasmic m 6 A binding proteins YTHDF1 and YTHDF2, YTHDC1 is localized in YT bodies near the nuclear speckles [16] , supporting its association with pre-mRNA splicing. Xiao and colleagues [1] identified several YTHDC1 partners including five trans-acting splicing factors (serine/ arginine-rich splicing factors; SRSF1/3/9/7/10) by tandemaffinity purification following by mass spectrometric analysis, suggesting the potential regulatory role of YTHDC1 in premRNA splicing. To test such possibility, they measured the alternative splicing (AS) events using RNA-seq data upon knockdown of YTHDC1 and its potential SRSF partners in HeLa cells, respectively. Their findings indicate that YTHDC1
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-methyladenosine (m 1 A) at high resolution, suggesting a functional role for m 1 A in translation regulation [2, 3] . m 6 A reader YTHDC1 in pre-mRNA alternative splicing m 6 A is the most abundant endogenous mRNA modification, which is conserved across archea, bacteria, and eukaryotes [4] . Nonetheless, the importance of m 6 A in mammals had been underappreciated for about 40 years until the discovery of its reversibility by an m 6 A demethylase-fat mass and obesityassociated protein (FTO) [5] in 2011. Ever since, the widespread regulatory roles of m 6 A have been unraveled through the transcriptome-wide mapping of m 6 A modification [6, 7] , the characterization of the second m 6 A demethylase AlkB homolog 5 (ALKBH5) [8] and three subunits of m 6 A methyltransferase complex (methyltransferase like 3, METTL3; METTL14; and Wilms tumor 1 associated protein, WTAP) [9, 10] , and the functional studies of m 6 A readers YTH domain family protein 1 (YTHDF1) and YTHDF2 in humans, which regulates m 6 A methylated RNA stability [11] and translational efficiency [12] , respectively. In addition, m 6 A in primary microRNAs can be recognized by another m 6 A reader, the heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1), which consequently recruits DiGeorge syndrome critical region 8 (DGCR8) and DROSHA complex and promotes the maturation of microRNAs [13, 14] . YTHDC1, as reflected by its name, contains the YTH domain that selectively binds to m 6 A [15] . Unlike the other two cytoplasmic m 6 A binding proteins YTHDF1 and YTHDF2, YTHDC1 is localized in YT bodies near the nuclear speckles [16] , supporting its association with pre-mRNA splicing. Xiao and colleagues [1] identified several YTHDC1 partners including five trans-acting splicing factors (serine/ arginine-rich splicing factors; SRSF1/3/9/7/10) by tandemaffinity purification following by mass spectrometric analysis, suggesting the potential regulatory role of YTHDC1 in premRNA splicing. To test such possibility, they measured the alternative splicing (AS) events using RNA-seq data upon knockdown of YTHDC1 and its potential SRSF partners in HeLa cells, respectively. Their findings indicate that YTHDC1 and SRSF3 facilitate exon inclusion, while SRSF10 promotes exon skipping; however, silencing of other SRSF proteins (SRSF1, SRSF7, and SRSF9) has no significant effect on AS events. Photoactivatable ribonucleoside crosslinking and immunoprecipitation (PAR-CLIP) sequencing shows that the targeted regions of YTHDC1, SRSF3, and SRSF10 are enriched in the coding sequences (CDS) and the 3 0 untranslated regions (UTR). Through analyzing the targeted exons, they further confirmed the opposite roles of YTHDC1/SRSF3 and SRSF10 in AS regulation. The change of AS events on the transcripts targeted by both YTHDC1 and SRSF3 in HeLa cells with YTHDC1 or SRSF3 silenced shows similar features with that in METTL3-silenced HeLa cells, suggesting that YTHDC1 and SRSF3 co-regulates AS events in an m 6 Adependent manner.
Next, the authors set out to validate the interaction of YTHDC1 with either SRSF3 or SRSF10. PAR-CLIP data show that the YTHDC1 target regions are located closer to the binding sites of SRSF3 than those of SRSF10. In vivo and in vitro co-immunoprecipitation assay verifies that YTHDC1 directly interacts with SRSF3 and SRSF10 through the N-terminal of YTHDC1 and C-terminal of SRSF3 or SRSF10. The different AS events affected by YTHDC1/ SRSF3 and SRSF10 prompts them to speculate that SRSF3 and SRSF10 might competitively bind to YTHDC1. Indeed they confirm the hypothesis using competing pull-down assays. The authors then examine whether YTHDC1 regulates localization of SRSF3 and SRSF10. Immunostaining assays show that silencing of YTHDC1 reduces SRSF3 but increases SRSF10 in nuclear speckle. Interestingly, this phenomenon can be rescued by complementation of wild-type YTHDC1, but not YTHDC1 mutant without m 6 A binding ability, indicating that YTHDC1 regulates the subcellular localization of SRSF3 and SRSF10 in an m 6 A-dependent manner. Further RNA binding assay shows that YTHDC1 deficiency disrupts the RNA binding of SRSF3 but enhances that of SRSF10, which can be complemented by wild-type YTHDC1, but not an m 6 A-binding-defective variant. These results indicate that the impact of YTHDC1 on AS events relies on the presence of m 6 A and the binding ability of YTHDC1 to methylated RNA.
Clearly, the comprehensive analysis presented by Xiao et al. reveals that m 6 A reader YTHDC1 facilitates exon inclusion by recruiting RNA splicing factor SRSF3 but blocking SRSF10 for its access to the binding regions of its target mRNAs (Figure 1) . Indeed, apart from YTHDC1, m 6 A reader HNRNPA2B1 [14] and indirect m 6 A reader HNRNPC [17] are both involved in RNA splicing. What roles do these proteins play in AS? Are there any other splicing factors regulated by m 6 A? Does YTHDC1 play other regulatory role apart from splicing? These questions warrant further investigations.
The reversible and dynamic m 1 A methylome in eukaryotic mRNA m 1 A, another RNA adenosine methylation modification, has been identified in total RNA [18] , rRNA [19] , and tRNA [20] for decades. m A peaks with high confidence in 600 human genes [3] . Both studies show that most of the identified transcripts contain only one m 1 A peak. Unlike m 6 A peaks that are enriched in the last transcribed exon [6, 7, 23, 24] , m 1 A peaks are highly enriched within 5' UTR and near start codons.
According to the estimation of Dominissini and colleagues [2] , 20% genes contain a single m 1 A. Through the deep analysis, they find that m 1 A is associated with canonical and alternative translation initiation sites, as well as the first splice site. Therefore they presume that the first spicing reaction might guide m 1 A deposition. m 1 A prefers more structured regions with high GC content and low minimum free energy. It is of note that m 1 A level and distribution pattern in mouse embryonic fibroblasts (MEFs) and mouse embryonic stem cells A is a reversible modification and may play an important regulatory role on mRNA.
Collectively, the two studies by Dominissini and his colleagues [2] and Li and his colleagues [3] provide the first map of transcriptome-wide m A modifications. Future studies will focus on the identification and characterization of writer and reader proteins and functional roles of these two modifications. Given that m 6 A as an RNA structure switch affects RNA-protein interaction [17] , the RNA structure changed by m 1 A modification might also play certain functions. We expect more investigations to draw a more comprehensive picture of RNA modification story.
